Litcius/Paper detail

Nanotechnology Against The Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2): Diagnosis, Treatment, Therapy and Future Perspectives

Hamid Rashidzadeh, Hossein Danafar, Hossein Rahimi, Faezeh Mozafari, Marziyeh Salehiabar, Mohammad Amin Rahmati, Samaneh Rahamouz-Haghighi, Navid Mousazadeh, Ali Mohammadi, Yavuz Nuri Ertaş, Ali Ramazani, Irada Huseynova, Rovshan Khalilov, Soodabeh Davaran, Thomas J. Webster, Taras Kavetskyy, Aziz Eftekhari, Hamed Nosrati, Mehdi Mirsaeidi

2021Nanomedicine76 citationsDOIOpen Access PDF

Abstract

COVID-19, as an emerging infectious disease, has caused significant mortality and morbidity along with socioeconomic impact. No effective treatment or vaccine has been approved yet for this pandemic disease. Cutting-edge tools, especially nanotechnology, should be strongly considered to tackle this virus. This review aims to propose several strategies to design and fabricate effective diagnostic and therapeutic agents against COVID-19 by the aid of nanotechnology. Polymeric, inorganic self-assembling materials and peptide-based nanoparticles are promising tools for battling COVID-19 as well as its rapid diagnosis. This review summarizes all of the exciting advances nanomaterials are making toward COVID-19 prevention, diagnosis and therapy.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusMedicine2019-20 coronavirus outbreakIntensive care medicineNanotechnologyInfectious disease (medical specialty)DiseaseVirologyPathologyMaterials scienceOutbreakSARS-CoV-2 detection and testingCOVID-19 diagnosis using AISARS-CoV-2 and COVID-19 Research
Nanotechnology Against The Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2): Diagnosis, Treatment, Therapy and Future Perspectives | Litcius